Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
statement on the diagnosis of heart failure with normal left ventricular
ejection fraction by the Heart Failure and Echocardiography Associations of
the European Society of Cardiology. Eur Heart J 28, 2539-50.
Perreault S, Dragomir A, White M, Lalonde L, Blais L, Berard A (2009). Better
adherence to antihypertensive agents and risk reduction of chronic heart
failure. J Intern Med 266, 207 - 18.
Petrie M, McMurray J (2001). Changes in notions about heart failure. Lancet 358
(9280): 432-4.
Pieske B (2011). Heart failure with preserved ejection fraction—a growing
epidemic or ‘The Emperor’s New Clothes’?. Eur J Heart Fail 13: 11-13.
Pluim BM, Zwinderman AH, Van Der Laarse A, Van Der Wall EE (2000). The
athlete's heart. A meta-analysis of cardiac structure and function. Circulation
101, 336-44.
Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG (2001). Diastolic
dysfunction in normotensive men with well-controlled type 2 diabetes:
importance of maneuvers in echocardiographic screening for preclinical
diabetic cardiomyopathy. Diabetes Care 24, 5-10.
Post WS, Larson MG, Myers RH, Galderisi M, Levy D (1997). Heritability of left
ventricular mass: the Framingham Heart Study. Hypertension 30, 1025-8.
Purcell IF, Poole-Wilson PA (1999). Heart failure: why and how to define it? Eur J
Heart Fail 1(1): 7-10.
Redfield MM (2002). Heart failure – an epidemic of uncertain proportions. N Engl
J Med 347(18): 1442-4.
Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, Rodeheffer
RJ (2003). Burden of systolic and diastolic ventricular dysfunction in the
community: appreciating the scope of the heart failure epidemic. JAMA 289,
194-202.
Reitsma JB, Mosterd A, Koster RW, Van Capelle FJ, Grobbee DE, Tijssen JG
(1994). [Increase in the number of admissions due to heart failure in Dutch
hospitals in the period 1980-1992]. Ned Tijdschr Geneeskd 138, 866-71.
Reitsma JB, Mosterd A, De Craen AJ, Koster RW, Van Capelle FJ, Grobbee DE,
Tijssen JG (1996). Increase in hospital admission rates for heart failure in
The Netherlands, 1980-1993. Heart 76, 388-92.
Remes J, Miettinen H, Reunanen A (1991). Validity of clinical diagnosis of heart
failure in primary care. Eur Heart J 12(3): 315-21.
Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP,
Jacobsen SJ (2004). Trends in heart failure incidence and survival in a
community-based population. JAMA 292, 344-50.
Roger VL. (2009). Severity of myocardial infarction: new insights on an elusive
construct. Circulation 119(4): 489-491.
Roger VL, Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, Bell MR, Kors J,
Yawn BP, Jacobsen SJ (2010). Trends in incidence, severity, and outcome of
hospitalized myocardial infarction. Circulation 121, 863-9.
Rosenberg J, Shou M, Badskjaer J, Hildebrandt P (2009). Prognostic threshold
levels of NT-proBNP testing in primary care. Eur Heart J 30(1): 66-73.
Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972).
New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am
J Cardiol 30, 595-602.
Rutten FH, Grobbee DE, Hoes AW (2003). Differences between general
practitioners and cardiologists in diagnosis and management of heart failure:
a survey in every-day practice. Eur J Heart Fail 5, 337-44.
Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes
AW (2005). Unrecognized heart failure in elderly patients with stable chronic
obstructive pulmonary disease. Eur Heart J 26, 1887-94.
Pagina 110 van 122